Biotech softens its line
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The first signs of a peaceful settlement to the bitter row between British Biotech and its former head of clinical trials, Dr Andrew Millar, emerged last night, writes Terry Macalister.
Dr Millar said he would be willing to stop making public statements about the company after British Biotech indicated it would drop its legal action against him if he did so.
Dr Millar said: "I have said all I have to say about the company. I would be happy to talk to (chief executive) Dr McCullagh if he called me up.
"But sending me a writ for damages is a strange way to negotiate."
Dr McCullagh, commenting for the first time about a writ for damages served against Millar last Friday, said it was possible there could be an out of court settlement.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments